FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention refers to pharmaceutical industry, namely to a glucose-lowering transdermal plaster composition and can be used as a therapeutic agent for type 2 diabetes mellitus therapy. Transdermal plaster contains polyethylene glycol-400, ethyl alcohol 95 %, dimethylsulphoxide and plasdone K25, and the pharmacologically active component - glycazidum with the following ratio of components, g per 250 cm2: glycazide - 0.6; dimethylsulphoxide - 2.0; polyethylene glycol-400 - 2.0; plasdone K25 - 4.0; ethyl alcohol 95 % - 10.0.
EFFECT: disclosed patch has the capacity for prolonged storage with preservation of pharmacological activity for 2 years and soft form during storage with observance of temperature modes (not lower than +5 and not higher than +25 °C).
1 cl, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| MATRIX BASED ON ACRYLIC ADHESIVE WITH COMPLEX OF TRANSDERMAL TRANSFER ACTIVATORS FOR TRANSDERMAL THERAPEUTIC SYSTEMS | 2023 |
|
RU2812184C1 |
| TRANSDERMAL PLASTER | 2010 |
|
RU2445123C2 |
| PHARMACEUTICAL COMPOSITION OF ANTIDIABETIC ACTION IN SOLID DOSAGE FORM IN THE FORM OF TABLETS | 2022 |
|
RU2801279C1 |
| TRANSDERMAL PLASTER | 2010 |
|
RU2445084C2 |
| ANTIDIABETIC PHARMACEUTICAL COMPOSITION IN THE FORM OF SACHET | 2023 |
|
RU2817200C1 |
| MEDICINAL FILM CONTAINING MELATONIN FOR THE TREATMENT OF THERMAL INJURY | 2020 |
|
RU2751048C1 |
| METHOD FOR CORRECTION OF BLOOD SUGAR LEVEL AND TREATMENT OF PATIENTS WITH TYPE TWO DIABETES MELLITUS AND COGNITIVE DEFECTS | 2011 |
|
RU2467749C1 |
| AGENT SHOWING ANTIAGGREGATION ACTIVITY | 1991 |
|
RU2061481C1 |
| METHOD FOR PREPARATION OF DRUG WITH LOCALLY-ACTING ERYTHROPOIETIN | 2015 |
|
RU2611401C1 |
| HYPOGLYCEMIC AND IMMUNOMODULATORY AGENT PRODUCTION PROCEDURE | 2008 |
|
RU2356569C1 |
